Annovis Bio

(NYSE) ANVS

Current Price$1.97

Market Cap$64.10M

Since IPO (2020)-81%

5 Year-97%

1 Year-29%

1 Month-19%

Annovis Bio Financials at a Glance

Market Cap

$64.10M

Revenue (TTM)

$0.00

Net Income (TTM)

-$40.92M

EPS (TTM)

-$1.72

P/E Ratio

-1.08

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$1.97

Volume

118,531

Open

$1.91

Price

$1.97

Volume

118,531

Open

$1.91

Previous Close

$1.97

Daily Range

$1.91 - $2.06

52-Week Range

$1.54 - $5.50

Estimated Earnings Date

Aug 18, 2026

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$1.97

Volume

118,531

Open

$1.91

Previous Close

$1.97

Daily Range

$1.91 - $2.06

52-Week Range

$1.54 - $5.50

Estimated Earnings Date

Aug 18, 2026

ANVS News

Annovis Bio Narrows Loss in Q2

Motley Fool Markets TeamAug 12, 2025

Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday

Cory RenauerJul 29, 2021

doctor smiles while touching senior patient's arm

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Annovis Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Maria-Luisa Maccecchini, PhD

Website

www.annovisbio.com

Headquarters

Malvern, PA 19312, US

ANVS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-301%

Return on Capital

-12%

Return on Assets

-3%

Earnings Yield

-92.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$64.10M

Shares Outstanding

34.65M

Volume

118.53K

Avg. Volume

1.04M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$29.70M

EBITDA

-$29.70M

Operating Cash Flow

-$25.62B

Capital Expenditure

$0.00

Free Cash Flow

-$25.62B

Cash & ST Invst.

$19.53M

Total Debt

$0.00

Annovis Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$64.10M

N/A

Market Cap/Employee

$8.01M

N/A

Employees

N/A

Net Income

-$17.61M

-218.0%

EBITDA

-$18.01M

-186.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$14.22M

-36.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-2.52%

N/A

Return on Invested Capital

-12.00%

N/A

Free Cash Flow

-$9.01M

-11.3%

Operating Cash Flow

-$9.01M

-11.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$1.22+12.96%

PYPDPolyPid Ltd.

PYPDPolyPid Ltd.$4.83+2.33%

ELUTElutia Inc.

ELUTElutia Inc.$1.05+6.05%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.23+6.03%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$3.87+9.32%

CELUCelularity Inc.

CELUCelularity Inc.$1.00-2.45%

BCABBioAtla, Inc.

BCABBioAtla, Inc.$3.49+2.65%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$16.62-0.01%

STISolidion Technology

STISolidion Technology$22.71+3.51%

BBBlackBerry

BBBlackBerry$10.34+0.02%

FOXXFoxx Development

FOXXFoxx Development$5.25+0.84%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$36.02-0.03%

ONDSOndas

ONDSOndas$11.97+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.76+0.02%

Questions About ANVS

What is the current price of Annovis Bio?

Annovis Bio is trading at $1.97 per share.

What is the 52-week range for Annovis Bio?

Over the past 52 weeks, Annovis Bio has traded between $1.54 and $5.50.

How much debt does Annovis Bio have?

As of the most recent reporting period, Annovis Bio reported total debt of $0.00.

How much cash does Annovis Bio have on hand?

Annovis Bio reported $14.22M in cash and cash equivalents in its most recent financial results.

What is Annovis Bio’s dividend yield?

Annovis Bio does not currently have a dividend yield.

Annovis Bio

Annovis Bio Financials at a Glance

ANVS News

Annovis Bio Narrows Loss in Q2

Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday

Got $2,500? Check Out These 3 Alzheimer's Therapy Stocks

This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher

3 Biotech Stocks That Jumped Higher Last Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Annovis Bio

ANVS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Annovis Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ANVS

What is the current price of Annovis Bio?

What is the 52-week range for Annovis Bio?

How much debt does Annovis Bio have?

How much cash does Annovis Bio have on hand?

What is Annovis Bio’s dividend yield?

Premium Investing Services